Get early access! Join the Twelve Data AI Assistant waitlist now.
7.87200 EUR
0.2995
3.96%
Last update Sep 4, 8:22 AM CEST
Main market
Day range
7.87200
8.17200
Previous close
7.57250
Open
7.89000
Access this stock data via API
Subscribe
Innocan Pharma Corporation
7.87
0.30
3.96%

Financials

Income statement

Fiscal date Jun 2025 Mar 2025 Dec 2024 Sep 2024
Total reported revenue 6.0M 6.6M 4.6M 7.4M
Cost of revenue 691.6K 580.8K 846.0K 720.6K
Gross profit 5.3M 6.1M 3.8M 6.6M
Operating expense
Research & development 150.1K 153.5K 275.5K 321.5K
Selling general and admin 4.8M 5.5M 4.3M 6.0M
Other operating expenses
Operating income 337.7K 417.0K -783.7K 300.2K
Non operating interest income
Income 0 0
Expense 3.4K 2.6K 2.6K 1.7K
Other income expense -427.3K -386.3K 788.8K 300.2K
Pretax income -93.0K 28.1K 2.6K 598.7K
Tax provision 175.7K 223.4K 43.5K 356.5K
Net income -268.6K -195.3K -40.9K 242.2K
Basic EPS 0.0 0.0 0.0
Diluted EPS 0.0 0.0 0.0
Basic average shares 249.2M 247.6M 240.2M
Diluted average shares 249.2M 247.6M 240.2M
EBITDA 345.4K 425.5K -778.6K 307.9K
Net income from continuing op. -268.6K -195.3K -40.9K 242.2K
Minority interests -234.5K -301.0K -56.3K -489.5K
Preferred stock dividends
Main market

Exchange is currently active.
Closing in 9 hours 11 minutes

10:48
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CEST, UTC+02:00).